
SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2025, titled "Completion of USFDA inspection at Hyderabad manufacturing facility".
Filed with NSE ·

SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2025, titled "Completion of USFDA inspection at Hyderabad manufacturing facility".
6ix hasn’t read this filing yet.
SMS Pharmaceuticals Limited on 6ix
Follow SMS Pharmaceuticals into a list and get an email when it puts out news.
Follow SMS Pharmaceuticals